The Middle Molecule Hypothesis Revisited. Should Short, Three Times Weekly Hemodialysis Be Abandoned?

Bernard Charra1, Belding H Scribner2, Zbylut J Twardowski3

  • 1Centre de rein de Tassin, Centre de rein artificiel, Tassin, France.

Hemodialysis International. International Symposium on Home Hemodialysis
|April 30, 2017
PubMed

Insights

Middle molecules (MMs) are key uremic toxins. Current dialysis methods focusing on small molecules are insufficient, leading to poor patient outcomes. Longer, more frequent dialysis is essential for effective MM removal and improved survival.

Area of Science:

  • Nephrology
  • Uremic Toxin Research
  • Dialysis Efficacy

Background:

  • The middle molecule (MM) hypothesis, proposed in 1975, identified MMs as potential uremic toxins before their specific identification.
  • The Kt/Vurea concept became the standard for dialysis adequacy, focusing on small molecule removal.
  • Accumulating evidence over 20 years links MM accumulation to hemodialysis mortality, morbidity, and uremic symptoms.

Purpose of the Study:

  • To re-evaluate dialysis adequacy beyond small molecule clearance.
  • To highlight the critical role of middle molecules (MMs) in uremic toxicity.
  • To advocate for dialysis strategies that enhance MM removal.

Main Methods:

  • Review of accumulating evidence on MM toxicity and dialysis outcomes.
  • Comparison of MM removal characteristics versus small molecule removal during hemodialysis.
  • Analysis of clinical results from different dialysis schedules (frequency and duration).

Main Results:

  • MMs, including phosphate, are significant contributors to uremic toxicity and poor dialysis outcomes.
  • Standard dialysis based on small molecule removal (Kt/Vurea) does not adequately address MM accumulation.
  • Longer and more frequent dialysis sessions (e.g., daily or 6-7 times/week) significantly improve MM removal and clinical results.
  • MMs are slowly transferred from intracellular to extracellular fluid, requiring extended dialysis for efficient removal.

Conclusions:

  • Effective management of uremic toxicity necessitates substantial removal of middle molecules.
  • Current dialysis standards are inadequate due to insufficient MM clearance.
  • Achieving adequate dialysis requires longer sessions (minimum 5 hours, 3 times/week) or more frequent schedules (6-7 times/week) for optimal patient well-being and survival.

Related Concept Videos

Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.2K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.3K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
671
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.3K
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
2.0K
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.7K